Resistant Starch
Resistant Starch (RS)
A prebiotic fiber that resists digestion and feeds beneficial gut bacteria, supporting metabolic health, blood sugar control, and gut integrity.
Resistant Starch is a type of starch that 'resists' digestion in the small intestine and reaches the colon intact, where it's fermented by beneficial bacteria. This fermentation produces short-chain fatty acids, especially butyrate, which nourishes colon cells and has systemic benefits. There are four types of resistant starch, with Type 2 (from raw potato or green banana) and Type 3 (from cooked and cooled starches) being most commonly supplemented.
Mechanisms of Action
Butyrate Production
Fermented to produce butyrate
Prebiotic Effect
Feeds beneficial gut bacteria
Insulin Sensitivity
Improves glucose metabolism
Recommended Dose
15-30g daily
Loading: Start with 5g and increase by 5g weekly to minimize GI symptoms
Optimal Timing
- With meals
- Divide throughout day for higher doses
Take with food
Best Form
Raw potato starch (unmodified) or green banana flour
Alternatives: Hi-Maize resistant starch, Cooked and cooled potatoes/rice (food source)
Raw potato starch is economical and high in RS2. Do NOT heat - mix in smoothies, yogurt, or cold water. Hi-Maize is RS2 from corn.
Duration
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Mix with cold or room-temperature foods/liquids. Heat destroys resistant starch structure. Gradual dose increase is essential.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Improved Gut Health
Enhanced microbiome diversity and butyrate
Blood Sugar Control
Improved glucose response to meals
Increased Satiety
Feeling fuller for longer
Gas & Bloating
Common initial side effect
May help improve insulin sensitivity; monitor blood sugar
Who Should NOT Take This
- SIBO (may worsen symptoms initially)
- Severe IBS (start very slowly)
Drug Interactions
May improve insulin sensitivity and lower blood sugar; monitor glucose levels
Fiber may slow absorption of some medications; take medications separately
Possible Side Effects
Tip: Start very low (5g) and increase slowly over weeks
Tip: Reduces as gut adapts; increase gradually
Warnings
- Must start with low dose and increase gradually
- Do not heat - destroys resistant starch
- May significantly increase gas initially
Top studies from 40+ peer-reviewed papers
Juhász AE et al. • The American journal of clinical nutrition (2023)
“Galactomannans were the most effective dietary fiber for reducing the levels of HbA1c, fasting blood glucose, triglycerides, and LDL cholesterol in patients with type 2 diabetes.”
Key Findings:
- Galactomannans had the highest effect on reducing the levels of HbA1c (SUCRA: 92.33%) and fasting blood glucose (SUCRA: 85.92%).
- With regard to fasting insulin level, HOMA-IR, β-glucans (SUCRA: 73.45%), and psyllium (SUCRA: 96.67%) were the most effective interventions.
- Galactomannans were ranked first in reducing the levels of triglycerides (SUCRA: 82.77%) and LDL cholesterol (SUCRA: 86.56%).
- With regard to cholesterol and HDL cholesterol levels, xylo-oligosaccharides (SUCRA: 84.59%) and gum arabic (SUCRA: 89.06%) were the most effective fibers.
Snelson M et al. • Nutrients (2019)
“Short-term RS2 supplementation in humans is of limited cardiometabolic benefit.”
Key Findings:
- However, these outcomes were heavily influenced by positive results from a small number of individual studies which contradicted the conclusions of the majority of trials.
- RS2 had no effects on any other metabolic outcomes.
- All studies ranged from 1-12 weeks in duration and contained small sample sizes (10-60 participants), and most had an unclear risk of bias.
- Short-term RS2 supplementation in humans is of limited cardiometabolic benefit.
Tsitsou S et al. • Nutrients (2023)
“Additionally, more studies are needed to prove whether ingesting high-fiber carbohydrate-containing products per se can result in blunted glycemic and insulinemic responses and which DF type and amount are more effective.”
Key Findings:
- Data on insoluble DF and glucose metabolism are scarce.
- The same mixed results for glycemia can be seen in healthy volunteers with overweight/obesity, while resistant starch seems to improve insulinemic responses.
- Finally, more studies need to examine the acute effects of DF in starchy foods on glucose metabolism and insulin secretion in individuals facing glucose abnormalities.
- Additionally, more studies are needed to prove whether ingesting high-fiber carbohydrate-containing products per se can result in blunted glycemic and insulinemic responses and which DF type and amount are more effective.
Wei Y et al. • Nutrition and cancer (2022)
“Subgroup analysis shown that CRP level significant reduced in subjects from the east (SMD = -1.501; 95%CI: -2.662, -0.340; P = 0.011) or suffering from diseases (SMD: -1.057; 95%CI: -1.999, -0.115; P = 0.028).Supplemental data for this article is available online at https://doi.org/10.1080/01635581.2021.2019284.”
Key Findings:
- We used from the effect size, as estimated by the standardized mean difference (SMD) with 95% confidence intervals (95%CI) to perform the random method meta-analysis, with P value ≦0.05 as statistically significant.
- The 16 included trials with 17 effect sizes included a total of 739 participants in this paper.
- No significant effects on C-reactive protein (CRP) (SMD = -0.583; 95%CI: -1.270, 0.104; ), superoxide dismutase (SOD) (SMD = 0.091; 95%CI: -0.156, 0.338; ), and malondialdehyde (MDA) (SMD = -0.320; 95%CI: -0.907, 0.266; ).
Sobh M et al. • The American journal of clinical nutrition (2022)
“Available evidence suggests that RS supplementation is tolerated in both healthy subjects and in those with an underlying medical condition.”
Key Findings:
- Twenty-seven (69%) studies evaluated the impact of RS supplementation in healthy subjects whereas 12 (31%) studies included individuals with an underlying medical condition (e.g., obesity, prediabetes).
- Twenty-one (78%) studies reporting SCFAs used type 2 RS with a dose of 20-40 g/d for 1-4 wk.
- In 16 of 23 studies (70%), SCFA production was increased, in 7 studies there was no change in SCFA concentration before and after RS supplementation, and in 1 study SCFA concentration decreased.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.